Millions can be Protected from Heart Attack Via New Cholesterol Jab


Advertisement
by Kathy Jones on  May 12, 2012 at 7:08 PM Heart Disease News
PrintEmailComments Facebook Twitter StumbleUpon Digg Reddit Delicius RSS Feeds   Text 
Researchers claim that a new cholesterol-busting injection is a potential breakthrough in the battle against heart attacks and strokes.
 Millions can be Protected from Heart Attack Via New Cholesterol Jab

The medical world has been stunned after trials of the hoped-for miracle jab on volunteers found nearly three-quarters of a harmful form of artery--clogging cholesterol simply disappeared.

The experimental treatment, being developed in America, could be invaluable to those who have an intolerance to statins, the most commonly prescribed drug to combat high cholesterol.

The jab is still in the early stages of development and is unlikely to be available for at least four years but its early potential has excited medics.

"This is a very exciting development as it appears the drug has remarkable potential for helping lots of -people with high cholesterol," the Daily Express quoted James McKenney, the chief researcher, as saying.

"Every cardiologist who has seen the study has said, 'Wow'.

"We know the more you reduce a patient's bad cholesterol the better the chances of reducing coronary risk.

"If all goes well we should be able to reduce heart disease in a very substantial fashion. We are highly expectant but we are not there yet," he said.

People most at risk from harmful low-density lipoprotein (LDL) include those who have a high-fat diet, smoke and do not exercise.

Doctors recommend keeping blood levels of total cholesterol - essential for producing hormones and absorbing food - at a very low density.

One in five patients is resistant to statins and for many others even high doses do not sufficiently lower cholesterol.

The new drug, codenamed REGN727, has been developed from a class of medicines known as monoclonal antibodies or MABs, already being used in the fight against cancer.

It homes in on a protein known as PCSK9, stopping it from attaching to LDL and leaving it free to filter out unwanted fats.

The potential for a "holy grail" drug more effective than anything else on the market was so far-reaching that two major US companies, Sanofi US and Regeneron Pharmaceuticals, joined forces.

The trials were conducted by Virginia-based private medical research company National -Clinical Research and the results presented to the American -College of Cardiology.

Source-ANI
Do you like this Report?
0

 Email Email  RSS Feeds RSS Feeds  Print this page Print  Save this page Save  Link Link  Syndicate Syndicate  Comments Comments 
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Related Links

Heart Disease Related News

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
Quiz on Heart
A quiz on heart to learn more about its functions.
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
Cholesterol
Complete Medindia Resources
News Categories:  
Teen's Health Center